View in EDS PDF Full Text

Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.

Saved in:
Bibliographic Details
Title: Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
Authors: Palmieri, L., Papaleo, V., Porcelli, V., Scarcia, P., Gaita, L., Sacco, R., Hager, J., Rousseau, F., Curatolo, P., Manzi, B., Militerni, R., Bravaccio, C., Trillo, S., Schneider, C., Melmed, R., Elia, M., Lenti, C., Saccani, M., Pascucci, T., Puglisi-Allegra, S.
Source: Molecular Psychiatry. Jan2010, Vol. 15 Issue 1, p38-52. 15p. 1 Diagram, 2 Charts, 3 Graphs.
Subjects: Autism, Protein metabolism disorders, Developmental disabilities, Homeostasis, Physiology, Water-electrolyte balance (Physiology), Education
Abstract: Autism is a severe developmental disorder, whose pathogenetic underpinnings are still largely unknown. Temporocortical gray matter from six matched patient–control pairs was used to perform post-mortem biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier (AGC), which participates in the aspartate/malate reduced nicotinamide adenine dinucleotide shuttle and is physiologically activated by calcium (Ca2+). AGC transport rates were significantly higher in tissue homogenates from all six patients, including those with no history of seizures and with normal electroencephalograms prior to death. This increase was consistently blunted by the Ca2+ chelator ethylene glycol tetraacetic acid; neocortical Ca2+ levels were significantly higher in all six patients; no difference in AGC transport rates was found in isolated mitochondria from patients and controls following removal of the Ca2+-containing postmitochondrial supernatant. Expression of AGC1, the predominant AGC isoform in brain, and cytochrome c oxidase activity were both increased in autistic patients, indicating an activation of mitochondrial metabolism. Furthermore, oxidized mitochondrial proteins were markedly increased in four of the six patients. Variants of the AGC1-encoding SLC25A12 gene were neither correlated with AGC activation nor associated with autism-spectrum disorders in 309 simplex and 17 multiplex families, whereas some unaffected siblings may carry a protective gene variant. Therefore, excessive Ca2+ levels are responsible for boosting AGC activity, mitochondrial metabolism and, to a more variable degree, oxidative stress in autistic brains. AGC and altered Ca2+ homeostasis play a key interactive role in the cascade of signaling events leading to autism: their modulation could provide new preventive and therapeutic strategies. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 47126935
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Palmieri%2C+L%2E%22">Palmieri, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Papaleo%2C+V%2E%22">Papaleo, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Porcelli%2C+V%2E%22">Porcelli, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Scarcia%2C+P%2E%22">Scarcia, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Gaita%2C+L%2E%22">Gaita, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Sacco%2C+R%2E%22">Sacco, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Hager%2C+J%2E%22">Hager, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Rousseau%2C+F%2E%22">Rousseau, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Curatolo%2C+P%2E%22">Curatolo, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Manzi%2C+B%2E%22">Manzi, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Militerni%2C+R%2E%22">Militerni, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Bravaccio%2C+C%2E%22">Bravaccio, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Trillo%2C+S%2E%22">Trillo, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Schneider%2C+C%2E%22">Schneider, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Melmed%2C+R%2E%22">Melmed, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Elia%2C+M%2E%22">Elia, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Lenti%2C+C%2E%22">Lenti, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Saccani%2C+M%2E%22">Saccani, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Pascucci%2C+T%2E%22">Pascucci, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Puglisi-Allegra%2C+S%2E%22">Puglisi-Allegra, S.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Psychiatry%22">Molecular Psychiatry</searchLink>. Jan2010, Vol. 15 Issue 1, p38-52. 15p. 1 Diagram, 2 Charts, 3 Graphs.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Autism%22">Autism</searchLink><br /><searchLink fieldCode="DE" term="%22Protein+metabolism+disorders%22">Protein metabolism disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Developmental+disabilities%22">Developmental disabilities</searchLink><br /><searchLink fieldCode="DE" term="%22Homeostasis%22">Homeostasis</searchLink><br /><searchLink fieldCode="DE" term="%22Physiology%22">Physiology</searchLink><br /><searchLink fieldCode="DE" term="%22Water-electrolyte+balance+%28Physiology%29%22">Water-electrolyte balance (Physiology)</searchLink><br /><searchLink fieldCode="DE" term="%22Education%22">Education</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Autism is a severe developmental disorder, whose pathogenetic underpinnings are still largely unknown. Temporocortical gray matter from six matched patient–control pairs was used to perform post-mortem biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier (AGC), which participates in the aspartate/malate reduced nicotinamide adenine dinucleotide shuttle and is physiologically activated by calcium (Ca2+). AGC transport rates were significantly higher in tissue homogenates from all six patients, including those with no history of seizures and with normal electroencephalograms prior to death. This increase was consistently blunted by the Ca2+ chelator ethylene glycol tetraacetic acid; neocortical Ca2+ levels were significantly higher in all six patients; no difference in AGC transport rates was found in isolated mitochondria from patients and controls following removal of the Ca2+-containing postmitochondrial supernatant. Expression of AGC1, the predominant AGC isoform in brain, and cytochrome c oxidase activity were both increased in autistic patients, indicating an activation of mitochondrial metabolism. Furthermore, oxidized mitochondrial proteins were markedly increased in four of the six patients. Variants of the AGC1-encoding SLC25A12 gene were neither correlated with AGC activation nor associated with autism-spectrum disorders in 309 simplex and 17 multiplex families, whereas some unaffected siblings may carry a protective gene variant. Therefore, excessive Ca2+ levels are responsible for boosting AGC activity, mitochondrial metabolism and, to a more variable degree, oxidative stress in autistic brains. AGC and altered Ca2+ homeostasis play a key interactive role in the cascade of signaling events leading to autism: their modulation could provide new preventive and therapeutic strategies. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=47126935
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/mp.2008.63
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 38
    Subjects:
      – SubjectFull: Autism
        Type: general
      – SubjectFull: Protein metabolism disorders
        Type: general
      – SubjectFull: Developmental disabilities
        Type: general
      – SubjectFull: Homeostasis
        Type: general
      – SubjectFull: Physiology
        Type: general
      – SubjectFull: Water-electrolyte balance (Physiology)
        Type: general
      – SubjectFull: Education
        Type: general
    Titles:
      – TitleFull: Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palmieri, L.
      – PersonEntity:
          Name:
            NameFull: Papaleo, V.
      – PersonEntity:
          Name:
            NameFull: Porcelli, V.
      – PersonEntity:
          Name:
            NameFull: Scarcia, P.
      – PersonEntity:
          Name:
            NameFull: Gaita, L.
      – PersonEntity:
          Name:
            NameFull: Sacco, R.
      – PersonEntity:
          Name:
            NameFull: Hager, J.
      – PersonEntity:
          Name:
            NameFull: Rousseau, F.
      – PersonEntity:
          Name:
            NameFull: Curatolo, P.
      – PersonEntity:
          Name:
            NameFull: Manzi, B.
      – PersonEntity:
          Name:
            NameFull: Militerni, R.
      – PersonEntity:
          Name:
            NameFull: Bravaccio, C.
      – PersonEntity:
          Name:
            NameFull: Trillo, S.
      – PersonEntity:
          Name:
            NameFull: Schneider, C.
      – PersonEntity:
          Name:
            NameFull: Melmed, R.
      – PersonEntity:
          Name:
            NameFull: Elia, M.
      – PersonEntity:
          Name:
            NameFull: Lenti, C.
      – PersonEntity:
          Name:
            NameFull: Saccani, M.
      – PersonEntity:
          Name:
            NameFull: Pascucci, T.
      – PersonEntity:
          Name:
            NameFull: Puglisi-Allegra, S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2010
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-print
              Value: 13594184
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular Psychiatry
              Type: main
ResultId 1